By: Sara Riascos  Apr. 01, 2022
Chronic obstructive pulmonary disease (COPD) is frequently associated with hospital readmission. Readmission is a hospital quality measure that reflects dimensions of quality of inpatient care and also impacts overall programs by payors such as CMS’s Star Rating Program, HRRP and Value-Based Purchasing.Ventolin (Albuterol) is an Inhaled beta-2-agonist. Studies have shown the use of Ventolin (Albuterol) had an improvement in Chronic obstructive pulmonary disease (COPD) compared to the baseline. Other studies have shown the use of Ventolin (Albuterol) is safe for patients older than 4.
Read moreBy: Sara Riascos  Mar. 31, 2022
Chronic obstructive pulmonary disease (COPD) is frequently associated with hospital readmission. Readmission is a hospital quality measure that reflects dimensions of quality of inpatient care and also impacts overall programs by payers such as CMS’s Star Rating Program, HRRP and Value-Based Purchasing.Ventolin(Albuterol) is an Inhaled beta-2-agonist. Studies have shown the use of Ventolin (Albuterol) had an improvement in Chronic obstructive pulmonary disease (COPD) compared to the baseline. Other studies have shown the use of Ventolin (Albuterol) is safe for patients older than 4.
Read moreBy: Sara Riascos  Mar. 25, 2022
Chronic obstructive pulmonary disease (COPD) is frequently associated with hospital readmission. Readmission is a hospital quality measure that reflects dimensions of quality of inpatient care and also impacts overall programs by payers such as CMS’s Star Rating Program, HRRP and Value-Based Purchasing. Ventolin (Albuterol) is an Inhaled beta-2-agonist. Studies have shown the use of Ventolin (Albuterol) had an improvement in Chronic obstructive pulmonary disease (COPD) compared to the baseline. Other studies have shown the use of Ventolin (Albuterol) is safe for patients older than 4.
Read more